MITHRIL® Splints

MITHRIL® Splints

Designed for Clinicians, Built for Every Patient

MITHRIL Splints are next-generation casts designed to replace bulky, uncomfortable plaster casts. Manufactured using advanced bioplastic materials, MITHRIL Splints are lightweight, waterproof, radiolucent, and heat-mouldable, allowing clinicians to create a custom fit within minutes. Unlike conventional casting methods, MITHRIL adapts as patients heal, improving comfort, hygiene, and compliance throughout the recovery process.

Designed for trauma, neuro-rehabilitation, and post-operative care, MITHRIL Splints reduce application time, simplify clinical workflows, and eliminate many of the challenges associated with plaster. By combining modern materials with patient-centered design, MITHRIL represents a sustainable and scalable approach to immobilization for hospitals, clinics, and rehabilitation centers.

Cre-AID LABS

A pioneering FemTech and MedTech company incubated at IIT Bombay, dedicated to transforming maternal, fetal, and newborn healthcare through technology-driven innovation.

Cre-AID Labs is a Medical Technology startup headquartered in Bangalore, India. Proudly built under the Make in India initiative, we develop sustainable, patient-centric medical devices that improve recovery outcomes and clinical efficiency. Our flagship product, MITHRIL Splints, introduced in 2022, leverages bioplastic materials to offer a smarter alternative to traditional plaster casts. By combining innovation, sustainability, and accessibility, Cre-AID Labs is building the future of recovery- one that is faster, cleaner, and more comfortable for patients and clinicians alike.

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

For Patients

Lightweight and comfortable
Waterproof and hygienic
Custom-fit and adjustable
Improved compliance and recovery experience

For Clinicians

Fast application in minutes
Easy customisation and re-adjustment
Reduced complications and follow-up burden
Streamlined workflows and improved efficiency

For Healthcare Systems

Sustainable bioplastic construction
Reduced medical waste compared to plaster
Scalable across hospitals and rehabilitation settings
Supports modern, patient-friendly care delivery

IXanner® 7VN

IXanner® 7VN

The first portable handheld OCT designed for real-world accessibility .

The IXanner® 7VN is a breakthrough in Comprehensive eye diagnostics — the first portable handheld OCT designed for real-world accessibility. Compact yet powerful, it delivers high-resolution imaging without the bulk, cost, or infrastructure demands of conventional OCT systems. Its patented self-calibrating spectrometer ensures optimal signal alignment at every startup, reducing reliance on manual calibration and enabling consistent performance across hospitals, outreach camps, and home-care settings.

With certifications including UKCA, CE, ISO 13485, and CDSCO, IXanner® 7VN is regulatory-ready for deployment in India, the UK, and Europe. The device’s affordability (₹16 lakhs vs. ₹40–80 lakhs for traditional OCT) and portability make it uniquely suited for preventive eye care, diabetic screening, and pediatric diagnostics. By combining advanced optics with practical usability, IXanner® 7VN empowers clinicians and NGOs to expand access to eye health and reduce avoidable blindness globally .

MedevPlus

It is a medical technology company specializing in advanced optical design.

MedevPlus is a medical technology company specializing in advanced optical design. Our expertise has led to pioneering products such as Optical Coherence Tomography, Dental loupes and Laparoscopes, establishing a strong foundation in precision optics. Building on this, we developed the IXanner® 7VN, the first portable handheld OCT with patented spectrometer technology, now commercially available and transforming retinal imaging into a compact, accessible solution for hospitals, outreach programs, and home care.

Expanding beyond human diagnostics, MedevPlus has introduced the IXanner® VET, a veterinary OCT system capable of imaging animal retina and cornea with adaptive optics that adjust to varied axial lengths. In parallel, the IXanner® AEAR supports research and industrial applications, enabling imaging for drug efficacy testing, pathology, morphological studies, and broader industrial use in biotechnology and pharmaceuticals.

By combining deep optical expertise with cross-sector innovation, MedevPlus is positioned as a disruptive force in healthcare, veterinary diagnostics, and industrial imaging, delivering scalable solutions with global impact.

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

Portable & Handheld

First-of-its-kind OCT for hospitals, outreach, and home care.

Affordable

Costs ₹16 lakhs vs. ₹40–80 lakhs for conventional OCT.

Self-Calibrating Spectrometer

Auto-aligns components for optimal signal, reducing manual calibration.

Certified & Ready

UKCA, CE, ISO 13485, and CDSCO approvals ensure global deployment.

Versatile Use

Effective for preventive eye care, diabetic screening, pediatric diagnostics.

Veterinary Applications

Enables advanced imaging for animal ophthalmology and tissue diagnostics.

Industrial Applications

Supports biotechnology, pharmaceuticals, and manufacturing quality control.

Scalable Impact

Empowers NGOs, telemedicine, and public health initiatives to reduce avoidable blindness.

InoHealTM Pro Wound Healing Device

InoHealTM

InoHeal device is intended to be used for the healing of complex and difficult-to-heal wounds.

The InoHeal device is intended to be used for the healing of complex and difficult-to-heal wounds. It provides negative pressure wound therapy (NPWT) and/or Topical Oxygen Therapy (TOT) in a single, portable device, delivers both therapies seamlessly for cumulative benefits while reducing complexity.

The device facilitates wound healing by removing excess wound exudate and clearing infectious material and dead tissue debris, leading to accelerated wound healing. The InoHeal device is indicated for use on non-healing wounds with various etiologies such as traumatic wounds, venous leg ulcers, ischemic wounds, diabetic foot ulcers, pressure wounds, and post-surgical wounds.

INOHEAL automatically switches between NPWT and TOT cycles, without the need for any change of dressings, settings, device configuration, etc. Once the Combination Therapy cycle is setup and started, the device runs NPWT cycle and removes the exudate from the wound region, thereby removing any barrier that may have affected the absorption of oxygen. Immediately after the NPWT cycle, the INOHEAL system automatically switches to a TOT cycle and delivers 5x more oxygen than normal atmospheric pressure to the wound region.

Inochi Care Private Limited

Inochi Care is a MedTech start-up developing innovative solutions for wound care and management.

The company started from a biodesign fellowship at AIIMS Delhi & IIT Delhi. Inochi Care is an IP and tech-driven company with a focus on wound care products designed and engineered for scale and adoption across healthcare sectors and different markets. The technology development is inspired by “patient needs” as well as “healthcare provider needs”.

With our mission to “Healing the Non-healing wounds”, the first range of products is developed for accelerated healing of non-healing wounds including diabetic foot ulcers, pressure ulcers, and trauma wounds. Our goal is to reduce patient’s pain and suffering, decrease daily loss of productivity, and cut down the financial burden that results from non-healing wounds.

Inochi Care is funded and supported by Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC), Department of Science & Technology (DST), MeiTY , MedTech Innovator Asia Pacific, KIIT TBI, TiE Global. It has won several awards and recognitions for its innovative wound care products. In the past few years, we have won awards like Forbes Ignite Change Maker, TiE Global winner, the MedTech Innovator Asia Pacific Award, INAE Entrepreneur of the Year award, and the Leader in Innovation Fellowship (LIF Global) from the Royal Academy of Engineering, UK. In addition, Inochi Care has established collaborations with prestigious academic institutions, both national and global.

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

Accelerates wound healing through integrated NPWT and oxygen therapy
Improves wound bed preparation for closure or grafting
Shorten overall treatment duration without shifting between multi modal treatment
Integrates two advanced therapies into a single workflow
Helps reduce overall dressing complexity and clinician handling time
Supports healing in non-healing and complex surgical wounds

DOTO -Care Mother

DOTO -Care Mother

Maternal and fetal & labour monitoring solutions

CareMother’s maternal and fetal & labour monitoring solutions are designed to simplify pregnancy and labour monitoring while enhancing clinical efficiency and patient care. The platform combines portable wireless devices with AI-powered digital technology to enable real-time monitoring.

The solutions are ideal for hospitals, maternity centers, public healthcare programs, and rural health facilities, ensuring continuous and quality maternal care even in resource-constrained settings. By improving accessibility and reducing operational challenges, CareMother aims to support safer pregnancies, timely interventions, and better maternal and neonatal outcomes.

CareMother by Doto Health

A pioneering FemTech and MedTech company incubated at IIT Bombay, dedicated to transforming maternal, fetal, and newborn healthcare through technology-driven innovation.

CareMother by Doto Health is a pioneering FemTech and MedTech company incubated at IIT Bombay, dedicated to transforming maternal, fetal, and newborn healthcare through technology-driven innovation. Focused on bridging critical gaps in women’s healthcare, CareMother develops AI-powered medical devices, digital health platforms, and connected care solutions that make quality maternal healthcare more accessible, affordable, and scalable across urban, rural, and underserved communities.

The company’s ecosystem includes advanced fetal monitoring solutions such as Fetomax, Fetomax Twin, and BabyBeat; labor monitoring solutions like Nurtura; antenatal care kits under AnandiMaa; and neonatal care innovations such as ApneBoot. These solutions are integrated with intelligent digital platforms, including CareMother Connect and centralized monitoring dashboards, enabling real-time monitoring, remote access, clinical decision support, and continuum of care for healthcare providers.

Today, CareMother supports hospitals, clinics, governments, NGOs, and healthcare institutions across India and international markets including Africa and Southeast Asia. Through collaborations with leading healthcare organizations, public health agencies, and global innovation platforms, CareMother continues to strengthen its mission of improving maternal and newborn outcomes worldwide.

RG

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

Wireless and portable monitoring solutions
Real-time fetal and maternal health monitoring
AI-powered auto-interpretation and clinical decision support
AI-based alerts for timely risk identification and faster medical intervention
Digital partograph for smarter and more efficient labour monitoring
Remote monitoring with centralized dashboard access
Cloud-based digital data storage and automated reporting
Digital tools enable access to live reports from devices for doctors and clinics
Enhances patient engagement and communication through connected digital platforms
Easy-to-use interface for doctors, nurses, and healthcare staff
Supports hospitals, clinics, and rural healthcare setups

INGENE

INGENE – A Mini DNA Lab

INGENE is a compact, AI-enabled Mini DNA Lab designed to deliver fast and reliable genetic testing at the point of care.

INGENE is a compact, AI-enabled Mini DNA Lab designed to deliver fast and reliable genetic testing at the point of care. Using saliva swabs samples, INGENE automates DNA analysis and generates clinically actionable reports in under five hours.

The platform supports pharmacogenetics, preventive genomics, and infectious disease detection. Built with clinically validated markers and guideline-based recommendations, INGENE helps clinicians personalize treatment decisions while reducing adverse drug reactions. Its cloud-connected software and AI-driven analytics minimize manual intervention and improve consistency.

SmartQR Technologies Pvt. Ltd.

An AI-powered MedTech company focused on making advanced diagnostics and precision medicine accessible, affordable, and scalable.

SmartQR Technologies Pvt. Ltd. is an AI-powered MedTech company focused on making advanced diagnostics and precision medicine accessible, affordable, and scalable. The company combines genomics, molecular biology, artificial intelligence, and cloudbased analytics to build portable healthcare solutions for hospitals, diagnostic laboratories, research institutes, and public health programs. Its flagship platform, INGENE, enables rapid DNA analysis and AI-driven reporting to support preventive healthcare, pharmacogenetics, and infectious disease diagnostics.

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

Rapid turnaround time – results in under 5 hours
Non-invasive sample collection using saliva swabs or dried blood spots
AI-powered interpretation with comprehensive reports
Supports personalized medicine and pharmacogenetics
Clinically validated genetic markers
Minimal human intervention and reduced manual errors
Portable and scalable for hospitals and diagnostic labs
Cost-effective precision medicine solution

PRATHAMASENSE Genosensor

PRATHAMASENSE

World's first paper-based electrochemical DNA biosensor

Portable, table-top device detecting microbial infections and antibiotic resistance genes in under 90 minutes — no culture, no PCR required. Uses patented paper-based electrochemical technology with AI-enabled signal interpretation. Indian patent granted; US patent published at USPTO.

Clinical panels validated

RAMJA Genosensor Pvt. Ltd.

MedTech startup focused on rapid infection diagnostics and antimicrobial resistance detection using paper-based DNA biosensor technology.

RAMJA Genosensor Pvt. Ltd. represents a significant milestone in India’s diagnostic innovation journey. It is fast-growing MedTech startup focused on rapid infection diagnostics and antimicrobial resistance (AMR) detection using innovative paper-based DNA biosensor technology.

The startup has developed rapid, portable, and cost-effective diagnostic solutions that can detect infections and AMR within 90 minutes. RAMJA Genosensor Won >50 Indian and International awards worth rupees >4 crore.

Ramja Genosensor is CDSCO and ISO-13485-2016 approved first IVD device and Manufacture in molecular platform .The RAMJA Genosensor aims to reduce diagnostic delays and support timely antibiotic treatment across hospitals, laboratories, and remote healthcare centers in India.

With innovations like PRATHAMASENSE and multiple infection detection panels, Ramja Genosensor is expanding its presence across India and contributing to the fight against antibiotic resistance and healthcare-associated infections.

RG

Add your company logo, name, and a short description — this is what visitors see first.

Your tagline goes here

What you offer

List up to 3 key offerings visible to visitors

e.g. "Diagnostic kits · Lab equipment · AMR solutions"

Drive visitors to your website or product page

Add a direct link and a call-to-action label — users click and land on your platform instantly.

One Platform for Multiple Biological Fluids

A single platform can process blood, urine, tracheal aspirates, sputum, and other biological fluids with ease.

High Throughput & Efficient Sample Processing

The technology enables rapid processing of large sample volumes with minimal workflow complexity.

Minimal Infrastructure Requirement

PRATHAMASENSE operates with basic infrastructure including a centrifuge, incubator, and standard biosafety setup.

Up to 90% Reduction in Human Resource Dependency

B.Sc., BMLT, and laboratory technicians can operate the system efficiently after one week of training.

Cloud-Based Real-Time Data Connectivity

The platform offers PDF ready report, with ICMR Recommended guideline, cloud-enabled real-time reporting, centralized monitoring, and instant clinical data access.

Operable in Low-Resource & Peripheral Settings

The system can function in peripheral healthcare centres with 24×7 power backup compatibility.

Improved Hospital Efficiency & Revenue Generation

Early diagnosis supports reduced ICU stay, faster patient discharge, and improved hospital revenue.

Strengthening Antimicrobial Stewardship

Rapid pathogen and AMR detection promotes evidence-based antibiotic usage and reduces antimicrobial resistance.

Scalable Across Healthcare Networks

The platform is scalable for deployment across tertiary hospitals, government programs, and peripheral diagnostic centers.